Recherche translationnelle en santé,
technologie pour la santé et recherche clinique
- > Nos équipes de recherche / Equipe iDREAM
- > Equipe iDREAM
- > Equipe iDREAM / Axe 1 : Thérapeutiques
Travaille sur
- > FIVE-WEEK INTRANASAL NERVE GROWTH FACTOR TREATMENT IS SAFE AND FAVORS BRAIN NEUROGENESIS
Nina Colitti, Franck Desmoulin, Wafae Labriji, Alice Le Friec, Lorenne Robert, Amandine Michaux, Fabrice Conchou, Carla Cirillo, and Isabelle Loubinoux,
FENS 2022 (Federation of European Neurosciences Societies) _ 9-13 juillet 2022 à Paris
- > FIVE-WEEK NERVE GROWTH FACTOR TREATMENT IS SAFE FOR BRAIN REPAIR
Nina Colitti, Franck Desmoulin, Wafae Labriji, Alice Le Friec, Lorenne Robert, Amandine Michaux, Fabrice Conchou, Carla Cirillo, and Isabelle Loubinoux,
ADPD 2022 (International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders) – 14-20 mars 2022 , Barcelone, Espagne.
Abstracts rédigés ou co-rédigés
- > 55- Long-Term Intranasal Nerve Growth Factor Treatment Favors Neuron Formation in de novo Brain Tissue.Front Cell Neurosci. 2022 Jul 19;16:871532. doi: 10.3389/fncel.2022.871532.
Colitti N, Desmoulin F, Le Friec A, Labriji W, Robert L, Michaux A, Conchou F, Cirillo C, Loubinoux I.
- > Strength and fine dexterity recovery profiles after a primary motor cortex insult and effect of a neuronal cell graft.Behav Neurosci. 2015 Aug;129(4):423-34. doi: 10.1037/bne0000067.
Vaysse L, Conchou F, Demain B, Davoust C, Plas B, Ruggieri C, Benkaddour M, Simonetta-Moreau M, Loubinoux I.